News from NIAID-Supported Institutions

National Institute of Allergy and Infectious Diseases sent this bulletin at 11/15/2012 03:54 PM EST


Visit us on the Web	Follow us on Twitter	Visit us on Facebook	Follow us on LinkedIn

Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:

Game Changer for Arthritis, Anti-Fibrosis Drugs
November 12, 2012—University of Utah

UNC, Vanderbilt Discover a New Live Vaccine Approach for SARS and Novel Coronaviruses
November 12, 2012—Vanderbilt University

BioCryst Broad-Spectrum Antiviral BCX4430 Highly Effective against Yellow Fever in a Preclinical Disease Model
November 12, 2012—BioCryst Pharmaceuticals, Inc.

These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).